McCain urges Trump to make good on promise to address high drug prices

McCain urges Trump to make good on promise to address high drug prices
© Greg Nash

Sens. John McCainJohn Sidney McCainMcConnell: 'Whoever gets to 60 wins' on immigration Meghan McCain: Melania is 'my favorite Trump, by far' Kelly says Trump not likely to extend DACA deadline MORE (R-Ariz.) and Tammy BaldwinTammy Suzanne BaldwinGreen group backs Sens. Baldwin, Nelson for reelection Dems press Trump for 'Buy American' proposals in infrastructure plan Protesters wearing blue fill hearing to protest Grassley ignoring 'blue slip rule' MORE (D-Wis.) on Monday called on President TrumpDonald John TrumpTillerson: Russia already looking to interfere in 2018 midterms Dems pick up deep-red legislative seat in Missouri Speier on Trump's desire for military parade: 'We have a Napoleon in the making' MORE to make good on his promise to lower drug prices, writing that the problem "is only getting worse." 

The Trump administration has yet to take substantive action toward reducing the cost of prescription drugs despite promising to do so several times last year and in his State of the Union address last month. 

"We write to urge you to make good on your promise and make fixing the problem of high drug prices a top priority for you and your administration," the senators wrote in a letter to Trump. 

McCain and Baldwin urged the administration to back their bill, which would require drug manufacturers to justify their pricing and provide a breakdown of expenses before increasing the costs of some medicines. 

"This will provide taxpayers, consumers and policymakers with more information, including research and development, marketing and advertising costs," the senators wrote. 

"Drug companies are making lifesaving treatments unaffordable and are forcing families, seniors, taxpayers and our health care system to continue to foot the bill for these price increases with no systematic transparency. It is clear that the market is broken."

The senators wrote that transparency is a "critical first step" in addressing high drug prices. 

"You promised to take on high drug prices as your top priority, so we urge you to call on leadership in Congress to take up and pass our bipartisan legislation," they wrote.